Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-25T20:47:35.932Z Has data issue: false hasContentIssue false
  • English
  • Français

The metabolic syndrome in patients with a prolonged psychotic illness within a community setting: age and gender issues

Published online by Cambridge University Press:  24 June 2014

T Lambert ,
C Pantelis  and
N Freeman
T Lambert
Affiliation:
Office for Psychiatric Evaluation and Educational NewMedia (OPEN) ORYGEN The University of Melbourne
C Pantelis
Affiliation:
Melbourne Neuropsychiatry Centre, The University of Melbourne, Melbourne, Australia
N Freeman
Affiliation:
Office for Psychiatric Evaluation and Educational NewMedia (OPEN)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Information
Acta Neuropsychiatrica , Volume 18 , Issue 6 , December 2006 , pp. 260
Copyright
Copyright © 2006 Blackwell Munksgaard

Background:

To measure the prevalence of the metabolic syndrome among patients with a prolonged psychotic illness being treated within a community setting and to examine gender- and age-stratified trends.

Methods:

The study sample consisted of patients receiving treatment in the midwest or northwest mental health regions of Melbourne, Australia, between February 2003 and February 2004. Of the 206 patients aged 18 years and over who were approached, 106 consented to participate, yielding a response rate of 52.7%. Participants were assessed for the presence of metabolic syndrome using the Adult Treatment Panel Guidelines-III).

Results:

Prevalence of the metabolic syndrome among patients within this population was 39.4% (an alternate method of determining the denominator, indicates a rate of ∼50%). Patients with the metabolic syndrome had a higher body mass index (31.73 vs. 28.82, P < 0.01) and increased triglyceride levels (3.49 vs. 1.70, P < 0.01) compared with patients without this syndrome. Men with the metabolic syndrome had lower mean high-density lipoprotein cholesterol levels (0.95 vs. 1.24, P < 0.01) compared with men without this syndrome. In general, there were distinct gender patterns of abnormality in the metabolic components, and age stratification shows increased relative risks in the young as contrasted with the older patients.

Conclusions:

The prevalence of the metabolic syndrome is high among people with a prolonged psychotic illness. Health professionals treating people within this population need to be monitoring their patients' physical health as well as looking after their mental well-being.